Please login to the form below

Not currently logged in
Email:
Password:

Unlicensed sex drugs seized by MHRA

Enforcement officers from the UK's Medicines and Healthcare products Regulatory Agency seize nearly USD 709,263 worth of unlicensed medicines

Enforcement officers from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) have seized nearly GBP 350,000 (USD 709,263) worth of unlicensed medicines.

The drugs were discovered on 1 August 2007 at a secure lock-up facility in Uxbridge, West London and included Kamagra tablets and sachets, Lovegra and Apcalis, which are manufactured in India, but are unlicensed and untested despite claiming to treat male impotence. Investigations are ongoing.

Danny Lee-Frost, MHRA's head of criminal operations, said: ìThe type of medicines we seized cannot be guaranteed to be acceptably safe because they have not gone through the correct licensing regulatory process. At best these medicines could be a waste of money, at worst they could be severely detrimental to your health.î

If an individual is convicted of offences under the Medicines Act 1968, they can be sentenced to a maximum of two years imprisonment and/ or an unlimited fine. Where appropriate the MHRA will use the Proceeds of Crime Act 2002 to determine whether or not benefits were accrued through criminal activity and will recoup illicit earnings if the individual is found guilty.

7th August 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics